Clinical Scorecard: Non-fluoroscopic Ablation Techniques for Right-Sided Supraventricular Tachycardia: A Comprehensive Guide and Retrospective Analysis
At a Glance
Category
Detail
Condition
Right-Sided Supraventricular Tachycardia
Key Mechanisms
Zero-fluoroscopy catheter ablation using electroanatomic mapping and intracardiac echocardiography.
Target Population
Patients with symptomatic and recurrent reentrant and focal arrhythmias.
Care Setting
Electrophysiology laboratory
Key Highlights
Zero-fluoroscopy interventions are feasible, efficient, and safe.
The prevalence of paroxysmal SVT is estimated at 332.9/100,000 individuals.
Catheter ablation is recommended as first-line treatment for symptomatic SVT.
The use of 3D electroanatomic mapping systems has reduced fluoroscopy use.
Occupational radiation exposure impacts reproductive health and fetal development.
Guideline-Based Recommendations
Diagnosis
Use of electroanatomic mapping for precise navigation and visualization.
Management
Catheter ablation as first-line treatment for symptomatic and recurrent SVT.
Monitoring & Follow-up
Evaluate procedural outcomes and monitor for complications post-ablation.
Risks
Risks associated with radiation exposure and orthopedic injuries from lead aprons.
Patient & Prescribing Data
86 consecutive patients undergoing ablation from May 2024 to April 2025.
Ablation procedures were performed using CARTO™ 3 EAM system and specific catheter types.
Clinical Best Practices
Discontinue beta-blockers and anti-arrhythmic drugs prior to the procedure.
Use ultrasound guidance for venous access to enhance procedural safety.
Employ intracardiac echocardiography for improved visualization during ablation.
